<DOC>
	<DOCNO>NCT01823614</DOCNO>
	<brief_summary>To date , work relate study HIV tropism , perform HIV B C subtypes . In studied sample , HIV variants subtype A virtually absent . However , existence show previously difference nucleotide sequence V3 loop env region subtype A subtypes virus . In Russian Federation subtype A HIV-1 predominant , , accord estimate , account 89 % newly diagnose case HIV infection . Thus , seem interesting effective study characteristic HIV-1 subtype A , associated tropism , Russian Federation . The primary objective determination prevalence R5 ( chemokine receptor 5 ) , X4 ( chemokine receptor 4 ) , R5X4-tropic variant HIV HIV-infected population Russia , analysis possible feature tropism virus belong subtype A .</brief_summary>
	<brief_title>Co-receptor Tropism Determination HIV-1 Subtype A Spread Russian Federation Using V3-based Genotyping Tools</brief_title>
	<detailed_description>This study multicenter , single-step ; estimation prevalence R5 , X4 , R5X4-tropic HIV variant population HIV-infected Russians naïve CCR5-antagonists antiretroviral ( ARV ) therapy . Additional study objective identify dependence R5- X4-tropic HIV variant relation duration infection , stage HIV infection , value CD4-lymphocytes ; compare prevalence R5- X4-tropic HIV variant cohorts naïve ARVT experience patient . The study consist single visit patient , follow procedure perform : obtain informed consent , initial evaluation possibility include patient study , stratification patient , quota cohort yet reach , inclusion patient study . Also detailed information collect date birth , place residence ( region , city ) , date 1st HIV+ immune blot test , route infection , estimation year ( month ) infection , stage HIV infection , know result CD4 cell count viral load measurement , well know scheme ARV therapy . Additionally , study provide single blood sampling ( 6.4 mL volume ) test tube order study HIV tropism sequence . It expect inclusion study complete within approximately 3 month , period may extend depend actual inclusion patient study center . The Coordination Center study Central Research Institute Epidemiology ( hereinafter — Coordination Center ) . Patient selection perform 13 participate center : - The Federal Research Methodological Center AIDS , Moscow - The North-West District AIDS Center , St. Petersburg - The St. Petersburg City AIDS Center , St. Petersburg - The Republican Clinical Hospital Infectious Diseases , St. Petersburg - The Volga District AIDS Center , Nizhny Novgorod - The Republic AIDS Center Republic Tatarstan , Kazan - The Southern District AIDS Center , Rostov-on-Don - The Ural District AIDS Center , Ekaterinburg - The Sverdlovsk Oblast AIDS Center , Ekaterinburg - The Yamalo-Nenets Autonomous District AIDS Center , Noyabrsk - The Siberian Federal District AIDS Center , Omsk - The Krasnoyarsk Regional AIDS Center , Krasnoyarsk The study include approximately 900 HIV-infected patient sex age 18 year old , citizen Russia . Patient select AIDS center Republican Clinical Hospital Infectious Diseases , participant study . List study participant include 12 AIDS center one Republican Clinical Infectious Diseases Hospital , expect number patient 70 people per participant . The minimum number patient include study must least 40 people participant , actual amount depend success patient recruitment study center . Starting 4th month study , competitive selection patient allow , end soon total number enrol patient reach 900 people . According objective study , HIV tropism patient receive ART different immune status , experience ART analyze , inclusion patient study take place accord follow quota : 1 . Naïve patient 1 . The level CD4-lymphocytes &gt; 500 ( optimum 16 ( 12-18 patient ) ) 2 . The level CD4-lymphocytes 350-500 ( optimum 16 ( 12-18 patient ) ) 3 . The level CD4-lymphocytes &lt; 350 ( optimum 16 ( 12-18 patient ) ) 2 . Patients experience ARV 1 . Obtains ART treatment &lt; 6 month ( optimum 8 ( 4-12 patient ) ) 2 . Obtains ARV therapy 6 month 3 year ( optimum 8 ( 4-12 patient ) ) 3 . Obtains ART treatment &gt; 3 year ( optimum 8 ( 4-12 patient ) ) If within 3 month start patient selection study impossible complete cohort , quota may revise . Scheme study procedure . The study procedures - Obtaining informed consent - In/exclusion criterion evaluation - Check patient belongs cohort quota reach - Filling Case Report Form study participant - Blood sample Laboratory procedure - Determination HIV tropism sequence - Determination HIV viral load† - Determination quantity CD4-lymphocytes† † Carried routine analysis necessary List estimate parameter . To study HIV tropism sequence , perform standard laboratory test , determine subtype HIV ( conduct Coordination Center selectively 10 % patient ) blood sample carry patient . Determination HIV tropism sequence . Procedure HIV tropism determination sample involve consistent implementation follow stage : extraction nucleic acid blood sample , amplification env gene HIV genome , determine nucleotide sequence result specific DNA product analysis mean Internet resource geno2pheno , locate http : //coreceptor.bioinf.mpi-inf.mpg.de/index.php . According instruction set reagent tropism study , two possible result : 1. clinical sample contain R5-tropic virus , 2. clinical sample contain non-R5-tropic virus . An important additional result value FPR ( false positive rate ) , reflect degree reliability HIV tropism sample . Therefore , FPR value also present report contain result analysis . Standard laboratory test . The standard laboratory test mean measure viral load plasma sample , well CD4 cell count . These study carry case routinely need . When perform , result provide Case Report Form study participant . Determination HIV subtype . Determination HIV subtype carry Coordination Center selectively 10 % patient receipt Coordination Center clinical sample study participant ( study center ) . Determination subtype include follow stage : extraction nucleic acid plasma sample , amplification fragment pol region HIV genome , determine nucleotide sequence obtain specific DNA product , bioinformatics analysis mean Internet application REGA Subtyping tool Comet . General information method statistical analysis . Parameters descriptive statistic calculate index patient human immunodeficiency virus calculate proportion patient show sign correspond categorical variable calculate mean value , standard deviation , median , 25 75 percentile , minimum maximum value distribution continuous variable patient result evaluation . Also proportion patient different region different stage disease , infect HIV variant different tropism calculate . Evaluation reliability difference categorical variable ( example , difference distribution HIV variant different tropism different region ) perform use chi-square test . Estimation reliability difference continuous variable ( eg , level HIV viral load ) perform use parametric ( eg , test , ANOVA ) nonparametric ( eg , Wilcoxon rank-sum test ) method . Univariate multivariate logistic ( dependent variable binary ) linear regression ( dependent variable continuous ) analysis use assess association exploratory ( eg , CXCR4-tropic variant ) dependent ( eg , level HIV viral load ) variable . All statistical test two-sided , 5 % significance level .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Patients confirm HIV infection Confirmation inform consent provide write Russian Federation citizenship Age 18 year old Absence pregnancy time obtain biological material Availability data date 1st positive immune blot test , date diagnosis formulation clinical diagnosis , result viral load analysis perform previous 3 month , measure CD4 cell count perform previous 3 month , information ongoing ARV therapy patient receive antiretroviral therapy Pregnancy time obtain biological material Patients receive cytotoxic agent due chemotherapy cancer Patients receive immunomodulatory drug Participation clinical trial experimental drug Experience use CCR5antagonists Any condition opinion investigator may affect evaluation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>tropism determination</keyword>
	<keyword>genotypic methodic</keyword>
	<keyword>R5-tropic variant</keyword>
	<keyword>X4-tropic variant</keyword>
</DOC>